LEIDEN UNIVERSITY MEDICAL CENTER

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 9246
 
  
 
C07K PEPTIDES 5131
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4202
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C08G MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 1119

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0263,155 T CELL RECEPTORS DIRECTED AGAINST THE PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA AND USES THEREOFMar 09, 16Sep 15, 16[A61K, C07K]
2015/0374,734 ACTIVATION OF iNKT CELLSFeb 20, 14Dec 31, 15[A61K, C08G]
2014/0323,345 NOVEL MARKERS OF PAPILLARY AND RETICULAR FIBROBLASTS AND USES THEREOFNov 23, 12Oct 30, 14[C12Q, G01N]
2013/0288,976 Methods for Determining the Presence or Risk of Developing Facioscapulohumeral Dystrophy (FSHD)Aug 18, 11Oct 31, 13[C12Q, G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9829489 Compositions and methods for the diagnosis of rheumatoid arthritisJul 22, 15Nov 28, 17[G01N, C07K]
9574015 Methods for treating muscle specific receptor kinase (MuSK) myasthenia gravis with the Ig1 domain of MuSKSep 15, 14Feb 21, 17[A61K, A61P, C07K]
9457073 Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activitySep 24, 13Oct 04, 16[A61K, C12N]
9078895 Method for treating ocular cancerDec 05, 13Jul 14, 15[A61K, G01N]
8614192 Method for treating ocular cancerJul 24, 07Dec 24, 13[A61K, A01N]
8470785 Method for treating ocular cancerSep 27, 11Jun 25, 13[A61K, A01N, A61B]
7550138 mutant and vaccines including the mutantAug 14, 07Jun 23, 09[A01N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0313,988 ARTERIVIRUSAbandonedSep 25, 13Nov 05, 15[A61K, C12N]
2015/0159,216 METHODS AND COMPOSITIONS RELATED TO THE SMCHD1 GENEAbandonedJun 18, 13Jun 11, 15[C12Q, C12N, G01N, C07K]
2011/0008,287 METHODS AND MEANS FOR THE TREATMENT OF HPV INDUCED INTRAEPITHELIAL NEOPLASIASAbandonedSep 10, 10Jan 13, 11[A61K, A61P]
7807369 Methods and means for the treatment of HPV induced intraepithelial neoplasiaExpiredApr 25, 06Oct 05, 10[C12Q]
2009/0220,473 ADIR RELATED POLYMORPHISMS AND APPLICATIONS THEREOFAbandonedFeb 22, 07Sep 03, 09[A61K, C07H, C12P, C12N, C07K]
2009/0220,534 METHODS FOR IDENTIFYING T-CELL EPITOPES ASSOCIATED WITH IMPAIRED PEPTIDE PROCESSING AND APPLICATIONS OF THE IDENTIFIED EPITOPESAbandonedMar 16, 07Sep 03, 09[A61K, C07H, C12N, C40B, C07K]
2009/0028,874 Synthetic Protein as Tumor-Specific VaccineAbandonedDec 24, 03Jan 29, 09[A61K, A61P, C07K]
2009/0023,630 Methods and Means for Use in Diagnostics and Treatment of DiabetesAbandonedJan 30, 06Jan 22, 09[A61K, C12Q, C12N, A61P, C07K]
2009/0004,162 Hecgf-1 Related Polymorphisms and Applications ThereofAbandonedJun 29, 06Jan 01, 09[A61K, C07H, C12N, C07K]
2008/0311,159 Methods and Means for Diagnostics, Prevention and Treatment of Mycobacterium Infections and Tuberculosis DiseaseAbandonedMar 31, 06Dec 18, 08[A61K, C12Q, A61P]
6611704 Apparatus for measuring the autofluorescence of the cornea of an eyeExpiredJul 27, 00Aug 26, 03[A61B]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.